|
The TechNet21 e-forum has, since its inception, sought to bring to its
readers the best in immunization news, research and discussion. The
forum has established itself as an important platform for immunization
personnel to ask questions, clarify doubts and share information.
TechNet21 now goes a step further and taps technology to make your
forum more interactive and lively. The new web forum gives you the
option to participate in the discussion either through email or directly
through the website.
You can also receive individual contributions by email as they are
posted on the site. [Click here to access your subscriber settings and
sign up for this feature.] Alternatively, you can opt for the
TechNet21 Digest, which distils the week's posts and briefly covers the
week's highlights on the website.
What you are now looking at is the first issue of the TechNet21
Digest. This week's issue summarises the preceding week's posts on
supportive supervision, field trials of a new syringe melter, and
accessibility to older essential vaccines.
Should you want to comment on a post or contribute a fresh post, use
the Comment/Contribute links that have been provided below each post.
Links have also been provided to access the entire discussion thread.
Please read through the FAQs to find answers to any questions that you
may have. If you require further clarifications, please write to the
moderator.
|
